Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow PurgingBone Marrow CellsWhole-Body IrradiationHematopoietic Stem Cell TransplantationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideTransplantation ConditioningLymphoma, Non-HodgkinCarmustineBusulfanMelphalanLiver TransplantationLeukemiaGraft SurvivalRemission InductionAntineoplastic Combined Chemotherapy ProtocolsRecurrenceBone and BonesHematopoietic Stem CellsEtoposideTreatment OutcomeLeukemia, Myeloid, AcuteTransplantation ChimeraAnemia, AplasticHodgkin DiseaseStem Cell TransplantationTissue DonorsCytarabineKidney TransplantationHematopoiesisBone Marrow DiseasesColony-Forming Units AssayTransplantation, IsogeneicSurvival AnalysisHistocompatibility TestingPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidMultiple MyelomaTime FactorsHistocompatibilityActuarial AnalysisSalvage TherapyHematologic NeoplasmsVincristineImmunosuppressive AgentsDisease-Free SurvivalSurvival RateGranulocyte Colony-Stimulating FactorLymphomaGraft RejectionFollow-Up StudiesRetrospective StudiesAcute DiseaseHeart TransplantationImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyMyelodysplastic SyndromesMice, Inbred C57BLPodophyllotoxinRadiation ChimeraT-LymphocytesHepatic Veno-Occlusive DiseaseLung TransplantationHematopoietic Stem Cell MobilizationLeukocyte CountDrug EvaluationAntigens, CD34Peripheral Blood Stem Cell TransplantationPrognosisCyclosporineBone Marrow ExaminationThiotepaGraft vs Host ReactionLymphocyte DepletionCell TransplantationHematologic DiseasesGraft vs Tumor EffectPrednisoneAntibodies, MonoclonalLeukocyte TransfusionOrgan TransplantationBlood Cell CountBone RemodelingHLA AntigensBone Marrow NeoplasmsProspective StudiesCell SeparationNeoplasm, ResidualChimeraSevere Combined ImmunodeficiencyPlatelet CountGranulocytesCell DifferentiationGranulocyte-Macrophage Colony-Stimulating Factor